GAPDHS
Basic information
Region (hg38): 19:35533455-35545319
Previous symbols: [ "GAPDS" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAPDHS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 2 |
Variants in GAPDHS
This is a list of pathogenic ClinVar variants found in the GAPDHS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35533546-G-A | not specified | Uncertain significance (May 24, 2023) | ||
19-35533558-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
19-35536819-G-C | not specified | Uncertain significance (Apr 23, 2024) | ||
19-35536831-C-A | not specified | Uncertain significance (Aug 08, 2022) | ||
19-35536831-C-T | not specified | Uncertain significance (Mar 14, 2024) | ||
19-35536854-G-C | not specified | Uncertain significance (Oct 20, 2021) | ||
19-35536860-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
19-35536869-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
19-35536873-A-G | not specified | Uncertain significance (Mar 28, 2024) | ||
19-35536879-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
19-35536915-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
19-35536942-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
19-35536965-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
19-35536966-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
19-35538308-T-C | not specified | Uncertain significance (Mar 30, 2022) | ||
19-35538324-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
19-35538335-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
19-35538591-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-35542353-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
19-35542365-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
19-35542375-C-G | not specified | Uncertain significance (Aug 03, 2022) | ||
19-35542529-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
19-35542550-A-G | Benign (Mar 29, 2018) | |||
19-35542950-C-T | not specified | Uncertain significance (May 14, 2024) | ||
19-35543359-C-T | not specified | Uncertain significance (May 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GAPDHS | protein_coding | protein_coding | ENST00000222286 | 11 | 11905 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000334 | 0.988 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.339 | 252 | 268 | 0.942 | 0.0000163 | 2631 |
Missense in Polyphen | 127 | 145.23 | 0.87446 | 1381 | ||
Synonymous | 2.87 | 71 | 109 | 0.650 | 0.00000712 | 846 |
Loss of Function | 2.25 | 11 | 22.5 | 0.488 | 0.00000126 | 232 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000777 | 0.000774 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000165 | 0.000163 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility (By similarity). {ECO:0000250}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Glycolysis and Gluconeogenesis;Metabolism of carbohydrates;Metabolism of proteins;Glycolysis Gluconeogenesis;Chaperonin-mediated protein folding;Metabolism;Association of TriC/CCT with target proteins during biosynthesis;Glycolysis;gluconeogenesis;Protein folding;glycolysis;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.271
Intolerance Scores
- loftool
- 0.771
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.91
Haploinsufficiency Scores
- pHI
- 0.0755
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.458
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.927
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gapdhs
- Phenotype
- reproductive system phenotype;
Gene ontology
- Biological process
- gluconeogenesis;glycolytic process;flagellated sperm motility;positive regulation of glycolytic process;canonical glycolysis
- Cellular component
- nucleus;cytosol
- Molecular function
- glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity;protein binding;NADP binding;NAD binding